Publication Date: 10 October 2019
Continuing Education Units: 10 October 2021
CREDITS: 2.0 AMA PRA Category 1 Credits(s)™

Course Description:

In this web-based program, physicians will learn how recent developments in continuous glucose monitoring have advanced the management of Type 1 and Type 2 diabetes. Supported by an educational grant from Abbott.

Course Objectives:

• Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best Implement CGM-based technologies into their overall diabetes care plans for patients with T1D and T2D.
• Analyze the rationale and evidence for recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies.
• Compare and contrast available CGM-facilitating monitoring technologies and pair such technologies with optimal patient profiles.
• Educate patients with diabetes about the rationale, evidence, and outcome- optimizing results associated with technology-based, patient-centric and physician-directed CGM monitoring strategies that can be used to effect optimal lifestyle, diet-, and pharmacology-based approaches to attaining guideline-based HA1c levels in patients with T1d and T2D.
• Identify which patients with diabetes are ideal candidates for a technology-based, patient-directed glucose monitoring system.
• Interpret and apply data and results from clinical trials and experts with experience in CGM-facilitating monitoring technologies to improve patient care, improve safety of drug therapy for T1D and T2D, detect and mitigate risk of hypoglycemia, improve patient- and physician-directed changes in antidiabetic therapy, reinforce the safe use of antidiabetic drugs, and facilitate patient-activated drug titration, glycemic monitoring and disease management.
• Translate landmark clinical studies focused on CGM-based technologies to the front lines of clinical practice in the diabetes and primary care setting; and understand the translational implications of deploying sensor-based, CGM-based technologies as a foundational approach to improving outcomes in patients across the spectrum of diabetes.
• Educate other clinical providers on the diabetes care team about the rationale, role, evidence, and outcome-enhancing results that are derived from employing technology-based CGM strategies—both patient- and physician-directed—across the broad spectrum of patients with diabetes.

Course Instructor Bio(s)

Headshot placeholder

Professor Fernando Gomez-Peralta, MD, PhD

Coordinator, Diabetes Group
Endocrinology and Nutrition Unit
Segovia General Hospital
Segovia, Spain
Headshot placeholder

Emma G. Wilmot, MD, PhD

Consultant Diabetologist
University Hospitals of Derby and Burton
Honorary (Consultant) Assistant Professor
University of Nottingham
Consultant Diabetologist,
Derby Teaching Hospitals NHS Foundation Trust
Derby, United Kingdom
Headshot placeholder

Professor Thomas Danne, MD

Professor of Pediatrics
Chief Physician, Department Head, General Pediatric, Diabetes, Endocrinology and Clinical Research
Children’s Hospital “AUF DER BULT”
Hanover Medical School,
Hanover, Germany
Headshot placeholder

William H. Polonsky, PhD, CDE

Behavioral Diabetes Institute
Associate Clinical Professor
University of California, San Diego
San Diego, CA, USA

attended a live program?




continuing medical education courses

Earn CME credits at no cost to you.